CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 726 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00715247
NCT00715247N/ACompleted
CompareCT.gov

Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes

University of Utah·observational·Posted Jul 15, 2008·Updated Oct 15, 2019

In Brief

An observational study for Polycythemia Vera and 2 related conditions. Completed, enrolled 726 participants across 1 site.

Detailed Summary

The purpose of this project is to find genes whose mutations cause Polycythemia Vera, Essential Thrombocythemia and Primary Myelofibrosis.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPolycythemia Vera, Essential Thrombocythemia, Myelofibrosis
CountriesUnited States
CollaboratorsMyeloproliferative Disorders-Research Consortium, National Cancer Institute (NCI)

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 15, 2008
Enrollment StartJul 1, 2006
Primary CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 12.4 yearsPosted 18.0 years ago